Skip to main content
. 2020 May 25;10:8629. doi: 10.1038/s41598-020-65043-8

Table 3.

Performance of RISK6 signature compared to the ACS 16-gene, Sweeney3 and Maertzdorf4 signatures in GC6-74 non-progressor vs progressor samples, collected within 6 months of TB diagnosis were included.

GC6-74 progressor vs non-progressor
AUC 95% CI p
RISK6 70.2% 58.5–81.8% 0.0002
ACS 16-gene 67.6% 60.2–75.0% <0.0001
Sweeney3 71.4% 61.2–81.7% <0.0001
Maertzdorf4 65.7% 54.4–77.1% 0.0003